Direct injection of pharmacological activators of AMPK into the hypothalamus promotes feeding (Andersson et al., 2004), whereas disruption of AMPKα2 in neurons expressing anorectic POMC-derived peptides leads to obesity due to reduced energy expenditure and increased food intake (Claret et al., 2007). Here, POMC is linked to obesity due to melanocortin 4 receptor deficiency.